_id
6915ec24bc934aba376b1d3f
Ticker
RAPH
Name
Raphael Pharmaceutical Inc.
Exchange
OTCQB
Address
4 Lui Paster, Jaffa, Israel, 6803605
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.raphaelpharmaceutical.com
Description
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.
Last Close
1.4
Volume
-
Current Price
1.4
Change
0
Last Updated
2026-01-06T09:59:31.209Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
27476984
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
251000
Operating Income
-251000
Interest Expense
-
Pretax Income
-255000
Net Income
-255000
Eps
-0.012992691789199639
Dividends Per Share
-
Shares Outstanding
19626418
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
3000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
5000
Property Plant Equipment
2000
Total Assets
7000
Payables
475000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1271000
Equity
-1264000
Bs_currency_symbol
USD
Depreciation
-
Change In Working Capital
199000
Cash From Operations
-17000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
0
Net Change In Cash
-17000
Cf_currency_symbol
USD
PE
-
PB
-21.73812120253164
ROE
20.174050632911392
ROA
-3642.857142857143
FCF
-17000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2
Value Investing Score
2.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
251000
Quarters > 0 > income Statement > operating Income
-251000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-255000
Quarters > 0 > income Statement > net Income
-255000
Quarters > 0 > income Statement > eps
-0.012992691789199639
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
19626418
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
3000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
5000
Quarters > 0 > balance Sheet > property Plant Equipment
2000
Quarters > 0 > balance Sheet > total Assets
7000
Quarters > 0 > balance Sheet > payables
475000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1271000
Quarters > 0 > balance Sheet > equity
-1264000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-255000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
199000
Quarters > 0 > cash Flow > cash From Operations
-17000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
0
Quarters > 0 > cash Flow > net Change In Cash
-17000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.012992691789199639
Quarters > 0 > ratios > PB
-21.73812120253164
Quarters > 0 > ratios > ROE
20.174050632911392
Quarters > 0 > ratios > ROA
-3642.857142857143
Quarters > 0 > ratios > FCF
-17000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
315000
Quarters > 1 > income Statement > operating Income
-315000
Quarters > 1 > income Statement > interest Expense
7000
Quarters > 1 > income Statement > pretax Income
-322000
Quarters > 1 > income Statement > net Income
-322000
Quarters > 1 > income Statement > eps
-0.016406457867146212
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
19626418
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
20000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
28000
Quarters > 1 > balance Sheet > property Plant Equipment
2000
Quarters > 1 > balance Sheet > total Assets
30000
Quarters > 1 > balance Sheet > payables
473000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1078000
Quarters > 1 > balance Sheet > equity
-1048000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-322000
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
284000
Quarters > 1 > cash Flow > cash From Operations
-30000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
0
Quarters > 1 > cash Flow > net Change In Cash
-30000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.016406457867146212
Quarters > 1 > ratios > PB
-26.218497328244272
Quarters > 1 > ratios > ROE
30.725190839694655
Quarters > 1 > ratios > ROA
-1073.3333333333333
Quarters > 1 > ratios > FCF
-30000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
425000
Quarters > 2 > income Statement > operating Income
-425000
Quarters > 2 > income Statement > interest Expense
4000
Quarters > 2 > income Statement > pretax Income
-429000
Quarters > 2 > income Statement > net Income
-429000
Quarters > 2 > income Statement > eps
-0.021858293245359393
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
19626418
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
50000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
91000
Quarters > 2 > balance Sheet > property Plant Equipment
2000
Quarters > 2 > balance Sheet > total Assets
93000
Quarters > 2 > balance Sheet > payables
379000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
827000
Quarters > 2 > balance Sheet > equity
-734000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-429000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
23000
Quarters > 2 > cash Flow > cash From Operations
-209000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
240000
Quarters > 2 > cash Flow > net Change In Cash
31000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.021858293245359393
Quarters > 2 > ratios > PB
-37.43458474114441
Quarters > 2 > ratios > ROE
58.44686648501363
Quarters > 2 > ratios > ROA
-461.2903225806452
Quarters > 2 > ratios > FCF
-209000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
39
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
394000
Quarters > 3 > income Statement > operating Income
-394000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-395000
Quarters > 3 > income Statement > net Income
-395000
Quarters > 3 > income Statement > eps
-0.021121393040891338
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
18701418
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
19000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
25000
Quarters > 3 > balance Sheet > property Plant Equipment
2000
Quarters > 3 > balance Sheet > total Assets
27000
Quarters > 3 > balance Sheet > payables
125000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
769000
Quarters > 3 > balance Sheet > equity
-742000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-395000
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
4000
Quarters > 3 > cash Flow > cash From Operations
-62000
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
41000
Quarters > 3 > cash Flow > net Change In Cash
-21000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.021121393040891338
Quarters > 3 > ratios > PB
-35.28569433962264
Quarters > 3 > ratios > ROE
53.23450134770889
Quarters > 3 > ratios > ROA
-1462.962962962963
Quarters > 3 > ratios > FCF
-62000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
39
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1509000
Annuals > 0 > income Statement > operating Income
-1509000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-1519000
Annuals > 0 > income Statement > net Income
-1519000
Annuals > 0 > income Statement > eps
-0.08122378741547834
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
18701418
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-8000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
19000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
25000
Annuals > 0 > balance Sheet > property Plant Equipment
2000
Annuals > 0 > balance Sheet > total Assets
27000
Annuals > 0 > balance Sheet > payables
125000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
769000
Annuals > 0 > balance Sheet > equity
-742000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1519000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
597000
Annuals > 0 > cash Flow > cash From Operations
-532000
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
321000
Annuals > 0 > cash Flow > net Change In Cash
-211000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.08122378741547834
Annuals > 0 > ratios > PB
-35.28569433962264
Annuals > 0 > ratios > ROE
204.7169811320755
Annuals > 0 > ratios > ROA
-5625.925925925926
Annuals > 0 > ratios > FCF
-532000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
1332000
Annuals > 1 > income Statement > operating Income
-1332000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-1344000
Annuals > 1 > income Statement > net Income
-1344000
Annuals > 1 > income Statement > eps
-0.07263719160404862
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
18502918
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-9000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
230000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
237000
Annuals > 1 > balance Sheet > property Plant Equipment
2000
Annuals > 1 > balance Sheet > total Assets
239000
Annuals > 1 > balance Sheet > payables
69000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
132000
Annuals > 1 > balance Sheet > equity
107000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-1344000
Annuals > 1 > cash Flow > depreciation
-
Annuals > 1 > cash Flow > change In Working Capital
-59000
Annuals > 1 > cash Flow > cash From Operations
-1203000
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1145000
Annuals > 1 > cash Flow > net Change In Cash
-58000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.07263719160404862
Annuals > 1 > ratios > PB
242.09425420560748
Annuals > 1 > ratios > ROE
-1256.0747663551401
Annuals > 1 > ratios > ROA
-562.3430962343095
Annuals > 1 > ratios > FCF
-1203000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
3317000
Annuals > 2 > income Statement > operating Income
-3317000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-3358000
Annuals > 2 > income Statement > net Income
-3358000
Annuals > 2 > income Statement > eps
-0.21492520500459547
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
15624040
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-38000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
288000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
331000
Annuals > 2 > balance Sheet > property Plant Equipment
2000
Annuals > 2 > balance Sheet > total Assets
333000
Annuals > 2 > balance Sheet > payables
72000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
227000
Annuals > 2 > balance Sheet > equity
106000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3358000
Annuals > 2 > cash Flow > depreciation
0
Annuals > 2 > cash Flow > change In Working Capital
309000
Annuals > 2 > cash Flow > cash From Operations
-759000
Annuals > 2 > cash Flow > capital Expenditures
2000
Annuals > 2 > cash Flow > cash From Investing
-2000
Annuals > 2 > cash Flow > cash From Financing
896000
Annuals > 2 > cash Flow > net Change In Cash
135000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.21492520500459547
Annuals > 2 > ratios > PB
206.35524528301886
Annuals > 2 > ratios > ROE
-3167.9245283018868
Annuals > 2 > ratios > ROA
-1008.4084084084085
Annuals > 2 > ratios > FCF
-761000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
13
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
1629000
Annuals > 3 > income Statement > operating Income
-1629000
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-1625000
Annuals > 3 > income Statement > net Income
-1625000
Annuals > 3 > income Statement > eps
-0.10494677099774995
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
15484040
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
6000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
153000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
92000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
422000
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
422000
Annuals > 3 > balance Sheet > payables
107000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
294000
Annuals > 3 > balance Sheet > equity
128000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1625000
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
206000
Annuals > 3 > cash Flow > cash From Operations
-1419000
Annuals > 3 > cash Flow > capital Expenditures
2000
Annuals > 3 > cash Flow > cash From Investing
-2000
Annuals > 3 > cash Flow > cash From Financing
1477000
Annuals > 3 > cash Flow > net Change In Cash
58000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.10494677099774995
Annuals > 3 > ratios > PB
169.3566875
Annuals > 3 > ratios > ROE
-1269.53125
Annuals > 3 > ratios > ROA
-385.07109004739334
Annuals > 3 > ratios > FCF
-1421000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
12
Valuation > metrics > PE
-0.012992691789199639
Valuation > metrics > PB
-21.73812120253164
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
20.174050632911392
Profitability > metrics > ROA
-5100
Profitability > final Score
55
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.010526315789473684
Liquidity > metrics > Quick Ratio
0.010526315789473684
Liquidity > final Score
11
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
55
Prev Profitabilities > 2
55
Prev Risks > 0
-150
Prev Risks > 1
-395
Prev Risks > 2
50
Prev Liquidities > 0
13
Prev Liquidities > 1
22
Prev Liquidities > 2
20
Updated At
2026-01-20T22:27:51.432Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.013
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.0164
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0219
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0211
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0174
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0133
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-03-31
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0295
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.0066
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0441
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0259
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0165
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops lead product candidate for the treatment of rheumatoid arthritis. It also intends to develop cannabinoid-based drug products for the treatment of oncology indications and other autoimmune diseases. The company is headquartered in Tel Aviv-Jaffa, Israel.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AShowing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Raphael Pharmaceutical Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.013
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.